We are live on ! Find out more
ASMB icon

Assembly Biosciences

34 hedge funds and large institutions have $143M invested in Assembly Biosciences in 2015 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 2

326% more capital invested

Capital invested by funds: $33.4M → $143M (+$109M)

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

42% more funds holding

Funds holding: 2434 (+10)

Holders
34
Holders Change
+10
Holders Change %
+41.67%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
12
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ASMB Hedge Fund Activity: Q1 2015 in Review

34 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2015, worth a combined $143M — up 326% from $33.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ASMB positions and 4 closed out — a net gain of 10 holders — while 12 added to existing stakes and 2 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $15.2M. The largest seller was Acuta Capital Partners, exiting entirely with an estimated $30K sold.

  • 34 institutional investors held Assembly Biosciences (ASMB) as of Q1 2015, up from 24 in Q4 2014.
  • Funds reported $143M of Assembly Biosciences stock for Q1 2015, up 326% quarter-over-quarter.
  • 14 funds opened new Assembly Biosciences positions in Q1 2015 and 4 closed out, a net change of +10 holders.
  • The largest Assembly Biosciences buyer in Q1 2015 was OrbiMed, an estimated $15.2M added.
  • The largest Assembly Biosciences seller in Q1 2015 was Acuta Capital Partners, an estimated $30K sold.

Based on aggregated 13F filings for Q1 2015.